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PERBANDINGAN GENOMIK METHICILLIN-RESISTANT Staphylococcus 
aureus PR01 (MRSA PR01) DAN METHICILLIN-SENSITIVE Staphylococcus 
aureus SA D22901 (MSSA SA D22901) SERTA DUA STRAIN DERIVATIF 
DARIPADA MSSA SA D22901 
ABSTRAK 
 
Staphylococcus aureus (S. aureus) adalah penyumbang utama jangkitan nosokomial 
manusia seluruh dunia. Kajian ini berjaya menghuraikan jujukan genomik beberapa 
spesis S. aureus, iaitu Methicillin-resistant Staphylococcus aureus (MRSA), yang 
dipencilkan daripada pesakit septisemia di Kuala Lumpur (MRSA PR01), pencilan 
klinikal Methicillin susceptible S. aureus (MSSA; SA D22901), serta dua strain ín 
vitro CR dan COR yang merupakan strain derivatif yang mempunyai rintangan 
terhadap antibiotik. CR dan COR telah dijana melalui dedahan SA D22901 kepada 
antibiotik ciprofloxacin, dan ciprofloxacin dan oxacillin, masing-masing. Jujukan 
genom S. aureus telah diperolehi melalui platform penjujukan genom generasi 
kedua. Data jujukan ini kemudiannya diproses melalui kombinasi pemasangan de 
novo dan perbandingan (de novo and comparative assemblies), penjelasan 
(annotation) dan pengemasan (finishing) genom untuk menghasilkan jujukan genom 
keseluruhan yang lengkap atau deraf. Genom MRSA PR01 telah dihuraikan ke taraf 
“non-contiguous finished”, manakala genom SA D22901 telah dihuraikan ke taraf 
“improved high quality draft”, dan strain-strain derivatif CR dan COR telah melalui 
pemasangan (assembly) secara “reference mapping” dengan menggunakan genom 
SA D22901 sebagai rujukan. MRSA PR01 didapati mempunyai corak rintangan 
antibiotik terhadap kebanyakan kelas antibiotik. Analisis pengetipan urutan 
multilokus (multi-locus sequence typing) mengesahkan ia adalah strain ST239 yang 
merupakan keturunan utama dalam kesihatan di seluruh dunia. SA D22901 
mengandungi profil MLST yang novel dan berlainan secara filogenetik dibanding 
xii 
  
dengan S. aureus yang terdapat di Malaysia. Selepas didedahkan kepada antibiotik, 
strain rintangan terhadap ciprofloxacin (dinamakan CR), serta ciprofloxacin dan 
oxacillin (dinamakan COR) berjaya dihasilkan. Analisis genom MRSA PR01 
menunjukkan bukti adaptasi untuk terus hidup selepas pendedahan terhadap 
antibiotik dan gen rintangan antiseptik dikodkan pada elemen bimbit genetik, sisipan 
kromosom besar dan mutasi titik dalam gen “housekeeping”. Analisis perbandingan 
MRSA klinikal dan MSSA menunjukkan peranan gen yang terlibat dalam 
pembentukan dinding sel dalam pengambilalihan rintangan methicillin. Analisis 
varian daripada kajian in vitro menunjukkan strain yang dijana memperolehi mutasi 
yang mungkin mencetuskan mekanisme evolusi rintangan terhadap ciprofloxacin dan 
oxacillin oleh S. aureus. Rintangan ciprofloxacin telah dicapai melalui mutasi dalam 
dua gen “topoisomerase”, manakala mutasi dalam gen yang terlibat dalam 
pembentukan dinding sel dan pelekatan sel ditemui dalam strain COR yang rintang 
terhadap oxacillin. Kesimpulannya, kajian ini berjaya menghasilkan jujukan genom 
keseluruhan beberapa strain S. aureus klinikal dan makmal dan mengenalpasti 
beberapa ciri utama yang terlibat dalam fenomena rintangan terhadap antibiotik. 
 
  
xiii 
  
COMPARATIVE GENOMIC OF METHICILLIN-RESISTANT 
Staphylococcus aureus PR01 (MRSA PR01) AND METHICILLIN-SENSITIVE 
Staphylococcus aureus SA D22901 (MSSA SA D22901) AND METHICILLIN 
RESISTANT DERIVATIVES OF THE LATTER 
ABSTRACT 
 
Staphylococcus aureus is a major contributor of nosocomial infections of humans in 
the world. This study elucidates the genomic sequences of an MRSA (MRSA PR01) 
isolate from a patient with septicaemia in Kuala Lumpur, a clinical methicillin-
susceptible S. aureus (MSSA) isolate (SA D22901), and two in vitro generated 
strains CR and COR which are derivatives of SA D22901 that developed resistance 
to antibiotics. CR and COR were isolated by exposing SA D22901 to become 
resistant to the antibiotics ciprofloxacin, and ciprofloxacin and oxacillin, 
respectively. These S. aureus strains were sequenced using a second generation 
sequencing platform. A combination of de novo and comparative assemblies, 
annotation and genome finishing was then applied to sequenced data to obtain the 
finished or draft genomes. The MRSA PR01 genome was sequenced to “non-
contiguous-finished” status, whereas MSSA SA D22901 was sequenced to 
“improved high-quality draft” status and the derivatives CR and COR were 
assembled using reference mapping to MSSA D22901. MRSA PR01 has an 
extended antibiotic resistance pattern, and is resistant to many classes of antibiotics. 
Multi locus sequence typing analysis determined it to be of type ST239, a prevalent 
healthcare lineage across the world. SA D22901 contains a novel MLST profile, and 
is phylogenetically diverse from other S. aureus strains found in Malaysia. Genomic 
analysis of MRSA PR01 provides evidence of its adaptation to survive in a health 
care setting through acquisition of drug and antiseptic resistance genes encoded on 
mobile genetic elements, large chromosomal insertions and point mutations in 
xiv 
  
housekeeping genes. Comparative analysis of the clinical MRSA and MSSA strains 
showed the importance of genes involved in cell wall synthesis in the acquisition of 
methicillin resistance. Variant analysis of the in vitro generated strains has 
uncovered mutations and mechanisms important in the evolution of ciprofloxacin 
and oxacillin resistance in S. aureus. Ciprofloxacin resistance was attained via 
mutations in two topoisomerase genes, while mutations in genes involved in cell wall 
synthesis and cell adhesion were found in the oxacillin-resistant COR strain. In 
conclusion, this study provided the whole genome sequences of several clinical and 
laboratory generated S. aureus strains and identified several key features that are 
involved in conferring antibiotic resistance. 
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CHAPTER ONE                                                                                             
 
INTRODUCTION 
1.1 Overview 
Genomics is the scientific study of the structure and function of genomes, i.e., the 
complete set of DNA within a cell of an organism (National Institutes of Health, 
2014). Structural genomics focuses on the construction of high resolution genetic, 
physical and transcript maps for each species(King, Stansfield, and Mulligan, 2007). 
Functional genomics expands the scope of research to the simultaneous study of 
large numbers of structural genes that respond to a suitable stimulus (King, 
Stansfield, and Mulligan, 2007). Evolutionary genomics contrasts the genomes of 
different species to follow evolutionary changes in genome organization. A common 
exercise in genomics is the in silico investigation of orthologs (King, Stansfield, and 
Mulligan, 2007).   
The pathogenic, Gram-positive bacterium S. aureus is a common cause of hospital 
infections.  Antibiotic resistance of S. aureus is fast becoming a major concern, as an 
increasing number of infections are caused by methicillin-resistant S. aureus strains 
that are resistant to most antibiotics in hospitals. The mechanism by which a strain 
acquires antibiotic resistance has been widely attributed to allelic diversity among 
strains. Therefore, studying the genome of the bacteria would enhance our 
knowledge about the mechanisms through which antibiotic resistance is attained.   
For this study, genomic DNA from an MRSA strain (source: clinical isolate) was 
sequenced using massively-parallel sequencing methods to produce millions of short 
reads that would be able to provide deep coverage of the genome. The reads were 
then assembled into contigs, annotated and then compared with other MRSA strains 
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as well as non-pathogenic S. aureus strains. The draft genome data can be further 
completed by employing primer-walking to close gaps between contigs. From there, 
various functional genetic studies can be undertaken to validate the findings of this 
study.  
Comparative genomic analysis of this MRSA strain to other MRSA strains would 
provide a clearer picture of the mechanism underlying multi-drug resistance. 
Comparative genomic analysis will also give a wealth of information on different 
aspects of the strain, such as epidemiological differences from MRSA strains found 
in other regions.  From this study, it is also possible to develop different methods for 
detection of MRSA strains in hospitals. 
Complementing this would be an in vitro study of the process by which antibiotic 
resistance was attained in S. aureus. This is achieved by the generation of multiple-
antibiotic resistant S. aureus strains from a parental, susceptible strain through 
antibiotic exposure. These strains were then sequenced using the same method as 
with the clinical MRSA strain. Comparative analysis of the strains was then 
performed to detect SNPs or other structural changes in the genome that had occurred 
after exposure to the antibiotics. 
Overall, this study attempts to investigate the occurrence of antibiotic resistance in S. 
aureus through the examination of the genomic sequences of strains that are resistant 
to various antibiotics. This study had two major components: firstly, the genome 
sequence of an MRSA strain was determined; secondly, antibiotic-resistant strains 
were generated in an in vitro manner and studied. The resultant laboratory-created 
MRSA genomes were compared with the genome of the clinical MRSA strain in 
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order to identify genetic elements of importance to antibiotic resistance. This is 
elaborated in further detail in Section 1.9. 
 
1.2 Pathogenicity of Staphylococcus aureus and the problem of increasing 
resistance to antibiotics 
The pathogenic, Gram-positive bacterium Staphylococcus aureus is a common cause 
of hospital acquired infections. This bacterium has been characterized as an 
opportunistic pathogen, and is extremely adaptive to its environment and host. About 
a third of humans are estimated to be asymptomatically colonized by S. aureus, 
hence it is considered normal flora (Gorwitz et al., 2008). Clinically important, it 
causes a wide variety of diseases in humans, e.g., nosocomial and community-
acquired infections, toxic shock syndrome, septicaemia, endocarditis and pneumonia 
(Lowy, 1998). 
Pathogenicity of the organism is compounded by the resistance mechanism of S. 
aureus to antibiotic treatment. Antibiotic resistance of S. aureus is a major concern, 
as an increasing number of infections are caused by methicillin-resistant S. aureus 
(MRSA) strains that are resistant to most antibiotics in hospitals. It was estimated 
that 90% of human S. aureus strains are resistant to penicillin (Klein, 2009). Strains 
of this class may also be resistant to other types of antibiotics. 
Historically, there have been four waves of antibiotic resistance in S. aureus each 
corresponding to the introduction of novel antibiotics in hospitals and the 
community. The first wave began in the 1940s with the incidence of penicillin 
resistant S. aureus (Barber and Rozwadowska-Dowzenko, 1948; Kirby, 1944) that 
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evolved as a response to the introduction of penicillin. Introduction of methicillin 
marked the onset of the second wave of resistance. This wave featured strains that 
were resistant to broad spectrum antibiotics which include penicillins, cephalosporins 
and carbapenems. This was different from the wave before, where strains had narrow 
resistance spectrum (Chambers and DeLeo, 2009). From this wave, a number of 
notable clones emerged, most prominently the “archaic” clone, one of the most 
successful of all MRSA lineages. The archetypal strain, COL is a member of this 
group and is the most studied MRSA isolate. This archaic clone of MRSA 
disseminated across hospitals in Europe until the 1970s, but was largely contained 
within the region and never gained a foothold across the rest of the world or into the 
community. The third wave of resistance occurred in the late 1970s and marked the 
rapid spread of successful MRSA lineages across the world. This wave established 
the successful lineages seen today, such as those shown in Table 1.1. The latest and 
ongoing fourth wave of resistance features MRSA invasion of the community, 
producing community-associated MRSA (CA-MRSA) clones (Henry F. Chambers 
and DeLeo 2009). 
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Table 1.1. Lineages of common nosocomial MRSA. 
Clonal 
Complex 
Multilocus 
sequence 
type 
Common names for 
specific MRSA clone 
Comment 
CC5 ST5 USA100 and New 
York/Japan clone 
Most common US 
healthcare-associated 
MRSA, SCCmecII 
 ST5 EMRSA-3 SCCmecI 
 ST5 USA800/Paediatric clone Prevalent in Argentina, 
Columbia, United States, 
SCCmecIV 
 ST5 HDE288/Paediatric clone 
(Portugal) 
SCCmecVI 
CC8 ST250 Archaic First MRSA clone 
identified, COL strain as an 
example; SCCmecI 
 ST247 Iberian clone and EMRSA-5 Descendent of COL-type 
strains, SCCmecI 
 ST239 Brazilian/Hungarian clone SCCmecIII 
 ST239 EMRSA-1 Eastern Australian epidemic 
clone of 1980s, SCCmecIII 
 ST8 AUS-2 and AUS-3 SCCmecII 
 ST8 Irish-1 Common nosocomial isolate 
in the 1990s in Europe and 
the US 
 ST8 USA500 and EMRSA-2,6 SCCmecIV 
CC22 ST22 EMRSA-15 International clone, 
prominent in Europe and 
Australia, SCCmecIV 
CC30 ST36 USA200 and EMRSA-16 Single most abundant cause 
of MRSA infections in 
United Kingdom; second 
most common cause of 
MRSA infections in US 
hospitals in 2003, 
SCCmecII 
CC45 ST45 USA600 and Berlin SCCmecII 
 
Note: Adapted from Chambers and DeLeo, 2009.  
Legend: SCCmec[number] refers to the type of SCCmec (Staphylococcal 
chromosomal cassette mec) found. This is elaborated more in Section 1.3.1.   
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1.3 The case for a genetic basis as the cause of adaptability of the 
organism to its environment  
Staphylococcus aureus is extremely dangerous as a pathogen because of its ability to 
adapt quickly to external pressures. A major way in which this ability manifests itself 
is through its ability to attain resistance to antibiotics quickly. The main mechanism 
by which this occurs is through Horizontal Gene Transfer (HGT) (Figure 1.1).  
Horizontal gene transfer is the process by which transfer of mobile genetic elements 
(MGEs) occurs between cells (Malachowa and DeLeo 2010). MGEs are short DNA 
sequences that frequently encode proteins that mediate the movement of DNA 
between bacterial cells or within genomes. Many resistance genes are carried on 
MGEs that will then act as vectors that transfer these genes to other bacteria of the 
same species, or of different genus or species. MGEs may consist of insertion 
sequences, transposons, phages, pathogenicity islands, and chromosome cassettes. In 
S. aureus, MGEs account for approximately 15-20% of the genome (Lindsay and 
Holden, 2006). This is contrasted with the typical method by which genetic material 
is passed on from parent to progeny via sexual or asexual reproduction, termed 
vertical gene transfer. HGT in prokaryotes occurs mainly through three mechanisms: 
Conjugation, transformation and transduction. 
Conjugation is the method by which transfer of genetic bacteria occurs between 
independently replicating bacterial cells, either by direct cell-to-cell contact or by a 
bridge-like connection between the two cells (Lederberg and Tatum, 1946). 
Conjugation is commonly associated with the transfer of plasmids between cells. 
Transformation is the natural uptake of exogenous genetic material from the cells’ 
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Figure 1.1. Horizontal Gene Transfer (HGT) in bacteria. The transfer of DNA 
encoding antibiotic resistance from bacteria that is naturally resistant to the antibiotic 
can be passed onto a susceptible bacterial cell via horizontal gene transfer. Due to the 
presence of selective pressures, the newly integrated DNA is then inherited by 
progeny, resulting in enrichment and proliferation of newly resistant bacteria. 
Adapted from (Malachowa and DeLeo, 2010). Appears as Figure 1 in original text. 
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surroundings through the cell membrane (reviewed by Chen and Dubnau, 2004). In 
fact, it was the observation of transformation of virulence determinants from 
pneumococci into infected mice that provided the first evidence that HGT could 
occur (Griffith, 1966; Thomas and Nielsen, 2005). There are only a number of 
prokaryotes capable of natural transformation, S. aureus among them.  The last 
mechanism, transduction is the process by which DNA is transferred from one 
bacterium to another by a virus, i.e., a bacteriophage (Zinder and Lederberg 1952). 
This method does not need physical contact between the donor and acceptor cell. 
Taken together, these three mechanisms of horizontal gene transfer explain the 
genetic basis by which antibiotic drugs become ineffective due to the transfer of 
antibiotic-resistance genes between bacteria (Frost et al., 2005). 
The bacterial genome consists of two different components: a core genome, 
containing all genes necessary for cell survival and an accessory genome, containing 
genes that encode for proteins required for adaptation of bacteria to their ecological 
niche. Genes that make up the core genome are highly conserved and are present in 
all strains of that species, whereas genes in the accessory genome tend to vary 
between strains and tend to be unique to that particular strain. Accessory genome 
differs from the core genome typically in GC content because they are usually 
obtained from other species through horizontal gene transfer mechanisms (Hacker 
and Kaper, 2000). Most MGEs are contained within the accessory genome. 
Staphylococcal MGEs consists of plasmids, transposons (Tn), insertion sequences 
(IS), bacteriophages, pathogenicity islands, and staphylococcal cassette 
chromosomes (Malachowa and DeLeo, 2010). Most genes encoded by MGEs are 
under the control of global regulators located within the core genome (Malachowa 
and DeLeo, 2010). 
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1.3.1 Genome features of Staphylococcus aureus 
The analyses of Staphylococcus aureus genomes have revealed several key features 
that characterize the organism. Central to methicillin resistance is the mecA gene, 
located on a genomic region known as the Staphylococcal chromosomal cassette 
(SCCmec) (Hiramatsu et al., 2001).  Most molecular tests for MRSA are designed to 
detect the presence of the mecA gene in S. aureus (Otte, Jenner, and Wulffen, 2005). 
SCCmec is a mobile genetic element characterized by the presence of terminal 
inverted and direct repeats, a set of site-specific recombinase genes (ccrA and ccrB) 
and the mecA gene complex (Hiramatsu et al., 2001; Ito et al., 2003). This element is 
integrated into the orfX gene (Berger-Bächi and Rohrer, 2002). To date, the SCCmec 
elements can be characterized into at least eight distinct types, with numerous 
subtypes and presumably many more to be discovered with the sequencing of more 
S. aureus strains (IWG-SCC, 2009). The mecA gene is responsible for the conference 
of resistance to β-lactam antibiotics, and is a major key feature present in all 
methicillin-resistant Staphylococcus aureus strains (Ubukata et al., 1989; Chambers, 
Hartman, and Tomasz 1985). The mecA gene encodes a low affinity penicillin-
binding protein (PBP), PBP2a that is expressed in addition to the complement of 
native PBPs and is the sole PBP in the presence of β-lactam antibiotics that is capable 
of maintaining cell wall integrity (Berger-Bächi and Rohrer, 2002). 
In addition to the above, specific to the Staphylococcus genome are regions within 
the Staphylococcus aureus genome that were thought to have arisen via horizontal 
gene transfer (Kuroda et al., 2001). These genomic regions have been termed νSaα, 
encoding multiple exotoxins (set) (Williams et al., 2000; Jarraud et al., 2001) and 
lipoproteins (lpl), and νSaβ, encoding multiple set and serine protease homologues 
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(spl) (Reed et al., 2001). Although stable (they are found in all S. aureus strains that 
have been sequenced so far), they vary in genetic composition and often carry genes 
involved in pathogenicity (Lindsay and Holden, 2006). 
Another class of Staphylococcus genomic features are super antigen encoding 
pathogenicity islands (SaPIs.), approximately 15 kb genomic regions which notably 
encode a number of virulence genes, including the superantigens toxic shock 
syndrome toxin-1 (tst) and enterotoxins B and C (seb, sec) (Yarwood et al., 2002). 
Superantigens are able to elicit a non-specific T-cell response, which then leads to 
massive cell expansion and shock. SaPIs themselves have been shown to be able to 
transfer horizontally in the presence of ‘helper’ phage (Lindsay et al., 1998).  
As mentioned in Section 1.3, MGEs play a vital role in the adaptability of the S. 
aureus genome. In S. aureus, a variety of MGEs are responsible for the antibiotic 
resistance and pathogenicity of the organism apart from those mentioned earlier. 
These include plasmids, transposons and bacteriophages (Malachowa and DeLeo, 
2010). 
Plasmids in S. aureus are divided into three types, class I-III based on their size and 
ability to conjugate (Lindsay and Holden, 2006). Class I plasmids are the smallest in 
size (<5kb) and have the highest copy number. They have been known to encode 
several resistance genes, e.g., tetracycline resistance is encoded by pT181 in COL 
(Khan and Novick, 1983; Gill et al., 2005).  Class II plasmids are larger (up to 40 kb) 
and usually contain resistance elements that were originally on transposons that have 
integrated into the plasmid. Class I and II plasmids are usually transferred by 
transduction. Class III plasmids are similar to Class II plasmids, except that they 
often also contain transfer (tra) genes that allow conjugative transfer of the plasmid 
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between bacterial isolates at low frequency on solid surfaces (Thomas and Archer, 
1989). This occurs because of the large size (up to 60 kb) of class III plasmids which 
may be too large to be transferred by transduction. 
In S. aureus, transposons are another MGE component that often encode for 
resistance genes. Transposons encode a transposase gene, the product of which 
catalyses excision and/or replication of the element, as well as integration. Horizontal 
transfer of transposons to other S. aureus cells is presumably by “piggybacking” onto 
another MGE, most likely a plasmid, which in turn can then be transferred by 
transduction or conjugation. An example of a transposon commonly found in S. 
aureus genomes is Tn554, which contains erm genes that encode for resistance to 
erythromycin (Phillips and Novick, 1979). Tn554 is also capable of integrating in 
multiple sites around the chromosome. Other examples include Tn552 which 
contains the blaZ gene that is associated with β-lactamase resistance (Rowland and 
Dyke, 1989); and Tn5801, a large transposon integrated into the Mu50 genome and 
encodes tetracycline resistance (tetM) (Kuroda et al., 2001). When the transposable 
elements lack additional genes, they are known as insertion sequences. 
The last major component of MGEs that make up a big part of the S. aureus 
accessory genome is bacteriophages, which are viruses that infect and replicate 
within bacteria. Bacteriophage genomic areas mainly contain virulence factors, such 
a sak (staphylokinase A thrombolytic enzyme) (Collen, 1998), chp (chemotaxis 
inhibitory protein and inhibitor of leucocyte migration) (Haas et al., 2004), sea 
(enterotoxin A, a common cause of food poisoning) (Betley and Mekalanos, 1985), 
eta (exfoliative toxin A, a cause of scalded skin syndrome) (Yamaguchi et al., 2000) 
and lukSF-PV (Panton–Valentine leucocidin implicated in haemolytic pneumonia 
and severe skin and soft tissue infections) (Kaneko et al., 1998; Narita et al., 2001). 
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Phages that have integrated into the bacterial chromosome are called prophages. 
These lysogenic phages are “dormant” and are replicated as part of the entire 
bacterial chromosome and passed to daughter cells during cell division (vertical 
transfer). Distribution of prophages in S. aureus strain populations has been shown to 
correlate with the clonal types of S. aureus (Goerke et al., 2009).This was shown in a 
study that classified Staphylococcal phages according to polymorphism of the 
integrase gene, which found that by linking the phage content to dominant S. aureus 
clonal complexes, the distribution of bacteriophages varied remarkably between 
lineages, indicating restriction-based barriers (Goerke et al., 2009). A comparison of 
colonizing and invasive S. aureus strains revealed that hlb-converting phages were 
significantly more frequent in colonizing strains (Goerke et al., 2009). 
Horizontal transfer of virulence factors by bacteriophage occurs in two ways: first, by 
transfer and integration of a bacteriophage that encodes a virulence gene on its 
genome (phage conversion); secondly, by generalized transduction. Generalized 
transduction (i.e., the transfer of bacterial DNA and not the phage DNA via 
transduction) in S. aureus is thought to be widespread and is the only feasible 
mechanism for the horizontal transfer of many non-phage MGEs (Lindsay and 
Holden, 2006).  
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Table 1.2. Mobile genetic elements (MGEs) in S. aureus. 
Type of MGE Mode of 
transfer 
Examples  Associated 
resistance/virulence 
elements 
References 
Plasmid Conjugation 
(Class III only), 
Generalized 
transduction 
 
pT181, 
pSAS 
tet, blaZ, cadD Massidda et 
al., 2006; Hou 
et al., 2007; 
Bismuth et al., 
1990 
Transposon “Piggybacking” 
onto another 
MGE, e.g., 
plasmid  
 
Tn554, 
Tn552, 
Tn5801 
ermA, spc, blaZ, 
tetM 
Westh et al., 
1995; Lelièvre 
et al., 1999; 
Rowland and 
Dyke, 1990, 
552; Bismuth 
et al., 1990 
Bacteriophage Transduction 
 
φ11, 
φETA 
sak, chp, sea, eta, 
lukSF-PV 
 
Collen, 1998; 
Haas et al., 
2004; Betley 
and 
Mekalanos, 
1985; 
Yamaguchi et 
al., 2000; 
Kaneko et al., 
1998; Narita 
et al., 2001 
Genomic 
island 
Unknown 
 
νSaα, 
νSaβ 
set, lpl, spl, lukDE Williams et 
al., 2000; 
Jarraud et al., 
2001; Reed et 
al., 2001 
Pathogenicity 
island 
 
Transduction  SaPI1, 
SaPImw2 
ear, tst ,seb ,sec Novick 2003; 
Yarwood et 
al., 2002 
Staphylococcal 
cassette 
chromosomes  
Unknown 
 
SCCmec mecA, far, cadA Ubukata et al., 
1989; 
Chambers, 
Hartman, and 
Tomasz, 1985; 
Dietrich, 
1992; M. 
Holden et al., 
2004) 
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1.4 Biological mechanisms of resistance 
 
In general, there are various ways in which a bacterial cell is able to attain resistance 
to an antibiotic. In Staphylococcus aureus, the main mechanism to which resistance 
is attained is dependent on the mode of action taken by the antibiotic in question. For 
instance, flouroquinones such as ciprofloxacin which inhibit bacterial growth by 
inhibiting the activity of DNA topoisomerase IV or DNA gyrase, can be neutralized 
by the presence of mutations that occur in the quinolone-resistance determining 
region (QRDR) of topoisomerase IV (encoded by the genes grlA and grlB) and DNA 
gyrase encoded by the genes gyrA and gyrB (Kaatz and Seo, 1997). However, 
fluoroquinolone resistance can also be mediated by drug efflux, a mechanism that is 
less well characterized (Tanaka et al., 2000). 
β-lactam resistance in Staphylococcus aureus is conferred by a few genetic elements. 
By far the most notable and studied is mecA operon on the staphylococcal cassette 
chromosome mec (SCCmec). The mecA gene encodes an altered penicillin binding 
protein (PBP2a or PBP2’) that has a lower affinity for binding β-lactams (penicillins, 
cephalosporins, and carbapenems) (Ubukata et al., 1989). This allows for resistance 
to all β-lactam antibiotics, and obviates their clinical use during MRSA infections.  
Aminoglycoside antibiotics, such as kanamycin, gentamicin and streptomycin were 
once effective against staphylococcal infections until strains evolved mechanisms to 
inhibit the action of aminoglycosides, which occurs via protonated amine and/or 
hydroxyl interactions with the ribosomal RNA of the bacterial 30S ribosomal 
subunit. There are three main mechanisms of aminoglycoside resistance which are 
currently and widely accepted: aminoglycoside modifying enzymes, ribosomal 
mutations, and active efflux of the drug out of the bacteria. 
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Resistance to macrolides such as erythromycin arises due to two distinct 
mechanisms. Erythromycin-resistant methylase is encoded by erm genes. Resultant 
structural changes to rRNA prevent macrolide binding and allow synthesis of 
bacterial proteins to continue. The presence of erm gene results in high-level 
resistance. Modification of the mechanism whereby antibiotics are eliminated from 
the bacteria also brings about resistance. Bacteria carrying the gene encoding 
macrolide efflux (mefE) display relatively low-level resistance.  
 
1.5 In vitro selection and characterization of antibiotic-resistant 
Staphylococcus aureus 
In order to explore further the mechanisms by which Staphylococcus aureus attains 
antibiotic resistance, it is possible to generate strains that attain resistance to different 
antibiotics in vitro, through the selection of resistant mutants (from an originally-
susceptible strain) by passage in broth culture containing subinhibitory 
concentrations of the antibiotic of choice. With the creation of these strains, it is then 
possible to analyse the genomes of these strains prior to and after exposure to that 
particular antibiotic using the same approaches whereby MRSA PR01 was 
characterized.  
 
1.6 Sequencing is an important tool for biological research 
DNA sequencing technology has advanced in leaps and bounds since the 
announcement of the completion of the Human Genome Project in 2000. This 
historic discovery ushered in an era of huge interest in genomics and molecular 
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biology for the purposes of biological and clinical research. Currently, a new wave of 
next generation sequencers provides a slew of different massively parallel 
sequencing strategies and platforms. One common platform is sequencing generated 
by the Illumina platform which utilises a ‘sequencing by synthesis’ approach to 
sequence DNA (Bentley et al., 2008). This approach is a reversible terminator-based 
method that enables detection of single bases as they are incorporated into extending 
DNA strands. A fluorescently-labelled terminator is imaged as each dNTP is added 
and then cleaved to allow incorporation of the next base.  All four reversible 
terminator-bound dNTPs are present during each sequencing cycle, minimizing 
incorporation bias.   
There are many applications in which DNA sequencing plays a role, most notably in 
the arena of genetics and genomics. For example, whole genome sequencing can be 
used as a tool to understand the evolution of antibiotic resistance. Mwangi et al. 
(2007) used this approach to follow the genetic changes that occurred at the start of 
vancomycin therapy and then sequenced the genome of a non-susceptible isolate 
recovered 3 months later. This study identified 35 point mutations that conferred a 
VISA phenotype and defined loci critical for multidrug resistance. These studies 
provide an illustration of how whole genome sequencing can be used to elucidate the 
molecular genetic basis of emerging antibiotic resistance. 
Another approach that has utilised whole genome sequencing to great effect is in the 
tracking of transmission in epidemiological outbreaks. Currently, genotyping is 
performed on S. aureus strains in order to type and characterize between different 
strains. One such method is multilocus sequence typing (MLST), a sequence based 
genotyping method that characterizes S. aureus strains based on the sequence of 450 
bp fragments of seven housekeeping genes. Isolates are grouped into clones based on 
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the allelic profile of the sequenced genes, and assigned a unique sequence type (ST). 
Sequence types that share at least five alleles in common with each other can be 
further grouped into clonal complexes (CCs) (Feil et al., 2001). Another similar 
method of MRSA typing is by the single locus DNA-sequencing of repeat regions of 
the Staphylococcus protein A gene (spa), termed spa typing (Koreen et al., 2004). 
These methods serve to provide identification and classification to different S. aureus 
strains. 
The aforementioned current molecular methods such as MLST and spa typing used 
to track and differentiate MRSA strains do so with limited discriminatory power. 
This is problematic, in light of the fact that single genotypic variants commonly 
predominate in the pathogen population. It has been shown, for example, that most 
human infecting MRSA strains are derived from one of 10 independent clonal 
complexes (Feil et al., 2003; Lindsay et al., 2006).  Several epidemiological studies 
have used the combination of whole genome sequence data of MRSA with 
epidemiological information to trace the transmission history of an MRSA outbreak 
(Nübel et al., 2013; Eyre et al., 2012; Köser et al., 2012). These studies have shown 
the ability of bacterial whole genome sequencing to distinguish between strains of 
MRSA collected within a short timescale in a confined geographic location (e.g. a 
hospital unit), hence supporting its potential as a routine tool in clinical bacteriology.  
 
1.7 Bioinformatics overview 
The term “bioinformatics” was first coined by the theoretical biologist Paulien 
Hogeweg in 1970, who at the time defined it as “the study of informatics processes in 
biotic systems” and used the term to describe the research themes that he and his 
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compatriots were working on, i.e., to understand biological systems as information 
processing systems (Hogeweg, 2011). With the advent of massive sequencing 
projects in the 1990s and 2000s, and the shift in molecular biology to become a 
heavily “data-driven” science, the definition of bioinformatics changed and 
developed into the field that it is known currently, as that of an “interdisciplinary 
toolset for applying computer science, mathematics, and statistics to the classification 
and analysis of biological information. At the highest level, bioinformatics is used to 
analyse large datasets to help answer biological questions, both in fundamental 
biology and in the biology that underlies disease”(Rothberg, Merriman, and Higgs,  
2012). 
Bioinformatics is also defined as conceptualising biology in terms of molecules (in 
the sense of physical chemistry) and applying  informatics techniques (derived from 
disciplines such as applied maths, computer science and statistics) to  understand and  
organise the  information associated with these molecules, on a large scale 
(Luscombe, Greenbaum, and Gerstein, 2001). In short, bioinformatics is a 
management information system for molecular biology and has many practical 
applications (Luscombe, Greenbaum, and Gerstein, 2001). Current work in 
genomics, proteomics, and many other “omics” research has produced a myriad of 
available software for many types of analyses.  
In the genomics era, biologists must attain, in addition to technical ability at the lab 
bench, considerable expertise in handling large datasets in arcane command line 
interfaces, and a considerable knowledge or computer programming or coding is 
required. The typical workflow for the elucidation of a bacterial genome is depicted 
in Figure 1.2.  
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Figure 1.2. An example of a workflow of the data analyses needed to elucidate the 
whole genome sequence of bacteria. 
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With the advent of next-generation sequencers there has been an exponential increase 
in the deposit of draft genomes into databases such as NCBI. However, these genome 
data cannot be held to the same standard as some of them may have been produced 
from low-quality data or through mis-assembly. Chain et al., (2009) proposed a new 
set of standards that fit the community-defined categories of standards that reflect the 
quality of the genome sequence based on the understanding of the available 
technologies, assemblers and efforts to improve upon drafted genomes. In this paper, 
they published a set of categories upon which genomes could be distinguished from 
each other based on combinations of technology, chemistry, assembler or 
improvement and/or finishing process. A summary of the categories is found in Table 
1.3.  
To attain these standards, several criteria must be considered including quality, 
coverage and assembly. Data quality is important in ensuring the validity of results, 
as is discussed further in Section 1.7.1. Coverage, or ‘depth’ of sequencing, refers to 
the number of times each nucleotide within the genome is expected to be sequenced 
taking into account the read length and number (Lander et al. 2001). It can be 
calculated from the length of the original genome (G), the number of reads (N), and 
the average read length (L) as  
𝑵× 𝑳 𝑮⁄  
Equation 1 
Coverage must be taken into account in order to generate high-quality, unbiased and 
interpretable data; however, it must also be balanced against the consideration of 
sequencing cost, which can be substantial (Sims et al., 2014). Key considerations in 
assembly will be discussed in Section 1.7.2. Complexity of the genome is also a main 
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factor that affects the quality of the resulting genome sequence. In this project, we 
aim to produce a genome sequence of at least ‘Non-contiguous-finished’ quality. 
 
 
Table 1.3. Categories of community-defined standards of assembled genomes. 
Adapted from (Chain et al. 2009) 
Table 1.3. (Continued)  
Category Description 
Standard Draft 
 
 Minimally or unfiltered data, from any number 
of different sequencing platforms, that are 
assembled into contigs.  
 Minimum standard for a submission to the 
public databases.  
 Likely harbour many regions of poor quality 
and can be relatively incomplete; may have 
contain contaminating sequence data. 
 Least expensive to produce and still possesses 
useful information. 
High-Quality Draft 
 
 Overall coverage representing at least 90% of 
the genome or target region.  
 Efforts should be made to exclude 
contaminating sequences.  
 Still considered a draft assembly with little or 
no manual review of the product.  
 Sequence errors and mis-assemblies are 
possible, with no implied order and orientation 
to contigs.  
 Appropriate for general assessment of gene 
content. 
Improved High-Quality 
Draft 
 Additional work has been performed beyond 
the initial shotgun sequencing and High-
Quality Draft assembly, by using either manual 
or automated methods.  
 Contains no discernible mis-assemblies and 
should have undergone some form of gap 
resolution to reduce the number of contigs and 
supercontigs (or scaffolds).  
 Undetectable mis-assemblies are still possible, 
particularly in repetitive regions.  
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Table 1.3. (Continued)  
Category Description 
 Low-quality regions and potential base errors 
may also be present.  
 This standard is normally adequate for 
comparison with other genomes. 
Annotation-Directed 
Improvement 
 
 May overlap with the previous standards, but 
the term emphasizes the verification and 
correction of anomalies within coding regions, 
such as frameshifts, and stop codons.  
 Used in cases involving complex genomes 
where improvement beyond this category fails 
to outweigh the associated costs.  
 Gene models (gene calls, including intron-exon 
determination for eukaryotes) and annotation 
of the genomic content should fully support the 
biology of the organism and the scientific 
questions being investigated.  
 Exceptions to this gene-specific finishing 
standard should be noted in the submission.  
 Repeat regions at this level are not resolved, so 
errors in those regions are much more likely.  
 This standard is useful for gene comparisons, 
alternative splicing analysis, and pathway 
reconstruction as most gene annotation at this 
stage is curated and of good quality. 
Noncontiguous Finished 
 
 High-quality assemblies that have been 
subjected to automated and manual 
improvement and where closure approaches 
have been successful for almost all gaps, mis-
assemblies, and low-quality regions.  
 Attempts have been made to resolve all gap 
and sequence uncertainties, and only those 
recalcitrant to resolution (e.g. repetitive or 
intractable gaps) remain (with notations in the 
genome submission as to the nature of the 
uncertainty).  
 Appropriate for most analyses.  
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Table 1.3. (Continued)  
Category Description 
Finished  
 
 Refers to the current gold standard; genome 
sequences with less than 1 error per 100,000 
base pairs and where each replicon is 
assembled into a single contiguous sequence 
with a minimal number of possible exceptions 
commented in the submission record.  
 All sequences are complete and have been 
reviewed and edited, all known mis-assemblies 
have been resolved, and repetitive sequences 
have been arranged in order and correctly 
assembled.  
 Remaining exceptions to highly accurate 
sequence within the euchromatin are 
commented in the submission.  
 The Finished product is appropriate for all 
types of detailed analyses and acts as a high-
quality reference genome for comparative 
purposes.  
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1.7.1 Data quality assessment 
Once data have been obtained, it is important to assess the quality of the reads that 
have been generated. The measurement of quality varies from platform to platform, 
but in the Illumina platform, quality scores measure the probability that a base is 
called incorrectly. With sequencing by synthesis (SBS) technology, each base in a 
read is assigned a quality score by a phred-like algorithm, similar to that originally 
developed for Sanger sequencing experiments (Ewing and Green 1998). The quality 
score of a given base, Q, is defined by the following equation: 
 
Q = -10log10(e) 
Equation 2 
 
where e is the estimated probability of the base call being wrong (Ewing and Green 
1998). Thus, a higher quality score indicates a smaller probability of error. As shown 
in Table 1.4, a quality score of 20 represents an error rate of 1 in 100, with a 
corresponding call accuracy of 99%. 
